Dosage forms

Pharvaris Presents Clinical Data on Oral PHA121 Supporting the Prophylactic Treatment of Hereditary Angioedema at the EAACI Annual Congress 2021

Retrieved on: 
Friday, July 9, 2021
Health sciences, Pharmacology, Dosage forms, Pharmaceutical sciences, Tablet, Capsule, Formulation, Modified-release dosage, Softgel

The data also show that PHA121 was well absorbed with median times to reach peak plasma levels within 1.00 to 1.75 hours after dosing with standard meals.

Key Points: 
  • The data also show that PHA121 was well absorbed with median times to reach peak plasma levels within 1.00 to 1.75 hours after dosing with standard meals.
  • Pharvaris remains committed to providing patients with oral alternatives both for on-demand and prophylactic treatment in HAE via our softgel capsule formulation, PHVS416, and extended-release tablet formulation, PHVS719.
  • Pharvaris is developing this formulation to provide rapid exposure of attack-mitigating medicine in a convenient, small oral dosage form.
  • Pharvaris is developing this novel small molecule for on-demand and prophylactic treatment of HAE and other bradykinin-mediated diseases through formulations optimized for each setting.

Loyal's Natural Wellness Products for Women Designed to Restore Balance to the Whole Body and Elevate Self Care, Now Available at Target

Retrieved on: 
Friday, July 9, 2021
Health sciences, Pharmacology, Dosage forms, Medical specialties, Feminine hygiene, Gynaecology, Women's health, Mammal female reproductive system, Vagina, Pantyliner, Cream, Suppository

All of Loyal's products, including suppositories, mists, creams, supplements, applicators and pH test strips will be carried by one of the largest retailers in the world.

Key Points: 
  • All of Loyal's products, including suppositories, mists, creams, supplements, applicators and pH test strips will be carried by one of the largest retailers in the world.
  • "We're thrilled that loyal's partnership with Target will empower women with the natural solutions they need for whole body love, while deconstructing the cultural shame surrounding feminine hygiene products," said Alex Stefanowitz, Director of Retail Sales at Loyal.
  • The Light Sleeper panty liner is pH balancing bamboo charcoal-infused layer designed to absorb discharge and maintain a balanced vaginal environment.
  • What started as a supplement company quickly became a passion project pivoting to natural wellness products after observing the current state of general vaginal health.

OnMi Transdermal Patches Now Available on OneLavi.com

Retrieved on: 
Friday, July 9, 2021
Health sciences, Pharmacology, Pharmaceutical sciences, Routes of administration, Dosage forms, Transdermal patch, Pharmacokinetics, Transdermal, Dermal patch, Prostate Adenocarcinoma: TransCutaneous Hormones, Sugar

PALM BEACH, FL, July 09, 2021 (GLOBE NEWSWIRE) -- American consumers, who have difficulty or dislike swallowing pills, now have easy and effective transdermal patches from OnMi available at OneLavi.com .

Key Points: 
  • PALM BEACH, FL, July 09, 2021 (GLOBE NEWSWIRE) -- American consumers, who have difficulty or dislike swallowing pills, now have easy and effective transdermal patches from OnMi available at OneLavi.com .
  • We are thrilled that OneLavi.com has chosen to offer OnMi patches to its consumers, said Ryan McFarlane, COO of OnMi, a Miami-based health and wellness company.
  • OnMi patches deliver vitamins and plant extracts without sugar and potentially harmful filler ingredients.
  • OnMi also recently introduced its transdermal patches to approximately 50 buyers from large and small retail chains in the United States.

$1.67 Billion Nebulizers Market - Global Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2015-2020 & 2021-2026 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 7, 2021
Pharmaceutical, Health, Other Health, Health sciences, Medical equipment, Respiratory therapy, Health care, Dosage forms, Aerosols, Health, Nebulizer

The "Nebulizers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Nebulizers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
  • The global nebulizers market reached a value of US$ 1.67 Billion in 2020.
  • Nebulizers are devices that are used by patients suffering from respiratory diseases to administer the medication directly into the lungs.
  • Key Questions Answered in This Report:
    How has the global nebulizers market performed so far and how will it perform in the coming years?

Alpine 4's Subsidiary, Alternative Laboratories, LLC Secures a New $2.0 Million Order Kicking Off Q3 2021

Retrieved on: 
Tuesday, July 6, 2021
Pharmaceutical industry, Dosage forms, Applied sciences, Labels, Chemical engineering, Tablet, Capsule, OTC Markets Group, Packaging and labeling, Natural sciences, Chemistry

PHOENIX, July 6, 2021 /PRNewswire/ -- Alpine 4 Holdings, Inc. (OTCQB: ALPP), a leading operator and owner of small market businesses, announces that its subsidiary Alternative Laboratories, LLC (Alt Labs), has secured a new $2,000,000 order for Q3 2021.

Key Points: 
  • PHOENIX, July 6, 2021 /PRNewswire/ -- Alpine 4 Holdings, Inc. (OTCQB: ALPP), a leading operator and owner of small market businesses, announces that its subsidiary Alternative Laboratories, LLC (Alt Labs), has secured a new $2,000,000 order for Q3 2021.
  • The company specializes in the manufacturing and packaging of liquids, powders, tablets, capsules, and other unique nutritionals for various customers worldwide.
  • Our Product formulation abilities and global raw material access, provides our clients with unique "first to market" products and cutting-edge innovations.
  • Mark Wesolaski, COO of Alternative Labs, had this to say: "We're very excited to start Q3 with an order of this magnitude.

Insights on the Sol-Gel Products Global Market to 2026 - Featuring 3M, CMR Coatings and Porcelain Industries Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, July 5, 2021
Other Manufacturing, Manufacturing, Physical sciences, Chemistry, Natural sciences, Dosage forms, Thin film deposition, Gels, Ceramic engineering, Sol–gel process

Silica based sol-gel coatings represents huge potential to be implemented in optical devices, like optical sensors and active coatings.

Key Points: 
  • Silica based sol-gel coatings represents huge potential to be implemented in optical devices, like optical sensors and active coatings.
  • Hence, owing to the above-mentioned factors, the sol-gel coatings application is likely to dominate the forecast period during the forecast period.
  • North America accounts for the largest market share in the global sol-gel products market currently with the major demand coming from the united states.
  • In the United States, the growing demand for sol-gel coatings from the aerospace industry is driving the demand for sol-gel products.

Global Pigmentation Disorders Treatment Market (2021 to 2026) - Growth, Trends, COVID-19 Impact and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Friday, July 2, 2021
Health, Pharmaceutical, Health sciences, Pharmacology, Dosage forms, Pharmacy, Topical medication, Cream, Lotion

Currently, topical treatment segment is dominating the global market due to the improved clinical outcomes in patients suffering from pigmentation disorders.

Key Points: 
  • Currently, topical treatment segment is dominating the global market due to the improved clinical outcomes in patients suffering from pigmentation disorders.
  • Topical treatment includes topical application of creams, lotions, ointments, and serums that are formulated using various active ingredients to treat different pigmentation conditions.
  • Additionally, topical corticosteroids (TC) application to treat pigmentation disorders is one of the most successful treatment options.
  • North America dominates the global pigmentation disorders treatment market owing to the rising pigmentation disorders.

Agile Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on Monday, July 26, 2021

Retrieved on: 
Thursday, July 1, 2021
Health sciences, Pharmacology, Routes of administration, Pharmacy, Dosage forms, Transdermal patches, Transdermal, Contraceptive patch, Patch

A live webcast will be available in the Events and Presentations section of the Investor Relations page at https://ir.agiletherapeutics.com/events-and-presentations/ , or by clicking here .

Key Points: 
  • A live webcast will be available in the Events and Presentations section of the Investor Relations page at https://ir.agiletherapeutics.com/events-and-presentations/ , or by clicking here .
  • Please log in approximately 10 minutes prior to the scheduled start time.
  • The archived webcast will be available in the Events and Presentations section of the company's website.
  • Twirla is based on our proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin.

Psilera Raises $2.5 Million with Oversubscribed Series Seed from Leading Institutional Investors to Accelerate Clinical Pipeline Focused on DMT

Retrieved on: 
Thursday, July 1, 2021
Health sciences, Pharmacology, Amines, Dosage forms, Ayahuasca, Entheogens, N,N-Dimethyltryptamine, Psychedelic drug, Transdermal patch, Investigational New Drug

Psilera has developed a patent-pending DMT transdermal patch to be assessed in a Phase 1b clinical trial with an investigational new drug (IND) filing anticipated in H2 2021.

Key Points: 
  • Psilera has developed a patent-pending DMT transdermal patch to be assessed in a Phase 1b clinical trial with an investigational new drug (IND) filing anticipated in H2 2021.
  • Transdermal administration can deliver drugs directly into the bloodstream and reduce DMT metabolism while providing steady, low-dose therapies.
  • This will be a major catalyst for Psilera to efficiently optimize its drug pipeline into lead candidates for clinical development.
  • About Psilera Bioscience - Psilera Inc. is a psychedelic-based biotechnology company developing its proprietary neuromodulator pipeline to target central nervous system disorders.

IV Therapy Franchise Plans to Open More Than 40 Locations This Year

Retrieved on: 
Wednesday, June 30, 2021
Medicine, Clinical medicine, Health sciences, Dosage forms, Injection, Intravenous therapy, Veins, Hydration

According to Chief Development Officer Ben Crosbie, THE DRIPBaR is expected to open as many as 40 locations this year.

Key Points: 
  • According to Chief Development Officer Ben Crosbie, THE DRIPBaR is expected to open as many as 40 locations this year.
  • This comes at a time when there are plans for 100s of new locations on the horizon.
  • Intravenous therapy, which is also known as IV therapy, is the administering of nutrients and hydration directly into the bloodstream for immediate absorption and use by the body.
  • With six locations currently open and operating, THE DRIPBaR already has nearly 200 additional locations in various stages of development across eight states.